Here are four high-yield blue-chip pharmaceutical stocks positioned to outperform and offer huge total return potential.

Data indicate that the LP.8.1-adapted COVID-19 vaccine confers improved immune response against currently dominant and emerging sublineages including the XFG and NB.1.8.1 variants1 compared to 2024-20 ...

Data indicate that the LP.8.1-adapted COVID-19 vaccine confers improved immune response against currently dominant and emerging sublineages - including the XFG and NB.1.8.1 variants1 - compared to ...

Many people have recently questioned the relevance of the COVID vaccine. However new study shows that it has a positive ...

A recent study revealed that cancer patients are at a significantly higher risk of contracting a severe COVID infection, but ...

COVID boosters reduced cancer patients’ hospitalizations and ICU stays by 29%, researchers report in JAMA Oncology. Overall, ...

While we have returned to many aspects of pre-pandemic life, the coronavirus has not completely disappeared.  Notably, cancer ...

Vaccine boosters help keep cancer patients from being hospitalized or admitted to intensive care units due to COVID-19, ...

A settlement has been reached in a class action investors’ lawsuit against Meta CEO Mark Zuckerberg and company leaders over ...

Cancer patients who receive COVID boosters are far less likely to be hospitalized, but vaccination rates remain alarmingly ...

Approximately 81 percent of the U.S. population received at least one dose of the COVID-19 vaccine, and now, researchers from ...